表纸
市场调查报告书

全球体外诊断药物(IVD)市场:2019评论和数据

IVDMARKETREACH: 2019 Global IVD Market Review and Data

出版商 EAC (Enterprise Analysis Corporation) 商品编码 968801
出版日期 内容资讯 英文
商品交期: 最快1-2个工作天内
价格
如有价格方面的疑问请按下「询问」键来信查询
全球体外诊断药物(IVD)市场:2019评论和数据 IVDMARKETREACH: 2019 Global IVD Market Review and Data
出版日期: 2020年11月05日内容资讯: 英文
简介

本报告调查了全球体外诊断(IVD)市场,并详细分析了140家关联公司的年收入,详细分析了北美,欧洲/中东/非洲各个领域的主要公司。提供有关日本,亚太地区和拉丁美洲每个地区的市场分析等信息。

报告摘要

  • 区域市场
    • 产品领域:WBGM,中央实验室免疫学,临床化学,POC/POL,临床化学,临床微生物学,血液学,解剖病理学,凝血,中央实验室急诊和重症监护,血液筛查免疫学,免疫血Gaku,血液筛查分子测试,中心实验室尿液测试,临床流式细胞仪等
    • 地区:北美,欧洲/中东/非洲,日本,亚太地区,拉丁美洲
    • 5年增长率:区域和部门增长矩阵
  • 在PowerPoint报告中附加了将以下内容概述的电子表格
    • 字段定义
    • 适用于部门和区域收入分配的先决条件
    • 汇总各种数据的图
    • 每个领域的趋势和发展评论
    • 关联公司亮点
  • 按领域划分的公司:基于各领域收入的主要公司
  • 分子:传染病,基因组学,样品制备/其他
  • POC/POL:主要公司和领域的利润
    • 心脏,HbA1c,凝血,血液学,化学,免疫测定,重症监护,尿液检查,分子等。

目录

体外诊断市场:

  • 在每个产品领域中表现最好的公司
  • 每个地区每个产品领域的分析和市场份额
  • 每个产品领域的分析以及每个地区的5年增长率

分子市场:

  • 每个领域的主要公司

POC/POL市场:

  • 每个领域的主要公司
  • 5年增长率
目录

2019 IVD market data derived from an in-depth analysis of annual revenues of the largest 140 IVD companies. Custom data subsets are available on request.

The full data set includes the following:

  • Disciplines by Region: Includes worldwide revenues for 16 disciplines by 5 regions with five year growth rates.
    • 16 disciplines include: WBGM, Central Lab Immuno, Clinical Chemistry, POC/POL, Clinical Molecular, Clinical Microbiology, Hematology, Anatomic Pathology, Coagulation, Central Lab Critical Care, Blood Screening Immuno, Immuno-Hematology, Blood Screening Molecular, Central Lab Urinalysis, Clinical Flow Cytometry and Other Products.
    • Regions include: North America, EMEA, Japan, Asia Pacific and Latin America.
    • 5 Year growth rates; matrix to provide growth by discipline by region.
  • A PowerPoint Report will accompany the spreadsheet outlining the following:
    • Discipline definitions
    • Assumptions applied to distributing revenues across disciplines and regions
    • Charts depicting available data
    • Selected commentary on trends and developments in each discipline
    • Company highlights
  • Companies by Disciplines: The top performing companies by revenue, operating within a discipline. Each category has an "other" category which will list the companies included.
  • Molecular: Worldwide revenues broken down across the top performing companies and by infectious diseases, genomics and sample preparation/other.
  • POC/POL: Worldwide revenues broken down across the top performing companies and 8 different disciplines.
    • 8 disciplines include: Cardiac, HbA1c, Coagulation, Hematology, Chemistry, Immunoassay, Critical Care, Urinalysis, Molecular and Other Products.
  • 5 Year growth rates; matrix to provide growth by discipline and for top 10 companies within each discipline.

Note: Subsets of the data (e.g., certain disciplines) or custom analysis are available upon request.

Table of Contents

The data will be delivered in 3 separate PDF files. The data reflects the following information:

IVD market:

  • Top performing companies across 16 disciplines
  • 16 disciplines across 5 regions with regional market share
  • 16 disciplines with 5 year growth rates by region

Molecular market:

  • Top performing companies across 3 segments

POC/POL market:

  • Top performing companies across 10 disciplines
  • 10 disciplines with 5 year growth rates